RESEARCH-USE BIOSIMILAR ANTIBODY

Panitumumab

Monoclonal antibody · IgG2

EGFRIgG2RUO

Panitumumab (ABX-EGF) is a fully human IgG2 anti-EGFR monoclonal antibody with anti-tumor activity. Panitumumab inhibits tumor cell proliferation, survival and angiogenesis. Panitumumab can be used in the research of cancers, such as colon cancer.

TARGETEGFR
YMonoclonal antibody
CATALOGSC-BS-293
CATALOG NUMBERSC-BS-293
MOLECULAR WEIGHTApprox. 144.32 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Panitumumab (ABX-EGF) is a fully human IgG2 anti-EGFR monoclonal antibody with anti-tumor activity. Panitumumab inhibits tumor cell proliferation, survival and angiogenesis. Panitumumab can be used in the research of cancers, such as colon cancer.

Panitumumab is a recombinant research-use antibody directed against EGFR.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Panitumumab | StellaCyte